Drug Monitoring: Clinical Trials

10 trials for Drug Monitoring, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 3 unknown, 2 completed, 1 active not recruiting. 7 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable7Completed 2, Unknown 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1
Phase 41Recruiting 1

Follow Drug Monitoring: new trials by email Literature Review of Drug Monitoring trials Research Report on Drug Monitoring

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Therapeutic Drug Monitoring of Mycophenolate Mofetil in Lupus Nephritis
Therapeutic Drug Monitoring, Standard clinical care - Systemic Lupus Erythematosus, Lupus Nephritis
Not applicableNot yet recruitingFederal University of Maranhao1002026-07-012026-03-25
Microsampling for Therapeutic Drug Monitoring of Oral Oncolytics in Oncology Patients
Therapeutic drug monitoring with a dried blood spot and microatainer. - Drug Monitoring
Not applicableRecruitingLeiden University Medical Center3602025-10-062025-11-21
Routinely Collected Clinical Data and Evaluation of Antimicrobial Target Attainment
Infections, Bacterial, Pharmacokinetics
RecruitingImperial College London3232024-03-192024-05-23
Influence of HLA-DQA1*05 Genotype in Adults With Anti-TNF Treatment With Proactive Therapeutic Drug Monitoring.
Tumor necrosis factor (TNF)-alpha inhibitors - Drug Monitoring, Inflammatory Bowel Diseases
UnknownHospital del Rio Hortega2802023-01-112023-08-14
Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels
Alectinib - Drug Monitoring, Carcinoma, Non-Small-Cell Lung
Phase 4RecruitingUniversity Medical Center Groningen1962022-03-232024-05-13
Plasma Protein Binding and PK/PD of Total and Unbound Temocillin Non-ICU Patients
temocillin - Pharmacokinetics, Antibacterial Agents
Not applicableUnknownPaul M. Tulkens602019-04-012022-05-31
Population Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive Care Units
blood sampling, Tissue sampling (lung), Collection of fluid samples - Pharmacokinetics, Anti-Bacterial Agents
Not applicableUnknownUniversité Catholique de Louvain202018-03-152022-05-25
Individualized Antiretroviral Therapy
Pharmacogenomic index, Therapeutic drug monitoring - Pharmacogenetics, HIV
Not applicableCompletedHospital Italiano de Buenos Aires1902017-10-052025-09-09
TDM Guided Early Optimization of ADAL in Crohn's Disease
Adalimumab - Crohn Disease, Drug Monitoring
Not applicableActive not recruitingwaqqas.afif2002017-01-172025-05-25
Quality of Life and Efficacy Evaluation of Patient Self-monitoring Their Oral Anticoagulation Therapy
Self-monitoring and adjustment of oral anticoagulation - Anticoagulants, Quality of Life
Not applicableCompletedMontreal Heart Institute1202009-10-012012-05-30

Narrower conditions

Bacterial Infections (3)  ·  Infections (2)  ·  Inflammatory Bowel Diseases (2)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Crohn Disease (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Lung Neoplasms (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Lupus Nephritis (1)  ·  Respiratory Tract Infections (1)

Broader conditions

Bacterial Infections and Mycoses (3)  ·  Digestive System Diseases (2)  ·  Gastroenteritis (2)  ·  Gastrointestinal Diseases (2)  ·  Intestinal Diseases (2)  ·  Respiratory Tract Diseases (2)  ·  Autoimmune Diseases (1)  ·  Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Chemically-Induced Disorders (1)  ·  Connective Tissue Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Glomerulonephritis (1)  ·  Immune System Diseases (1)

Interventions

Drug Monitoring (2)  ·  temocillin (2)  ·  Adalimumab (1)  ·  Blood Specimen Collection (1)  ·  Ceftriaxone (1)  ·  Meropenem (1)  ·  Tumor Necrosis Factor-alpha (1)  ·  Warfarin (1)  ·  alectinib (1)

Sponsors

Federal University of Maranhao (1)  ·  Hospital Italiano de Buenos Aires (1)  ·  Hospital del Rio Hortega (1)  ·  Imperial College London (1)  ·  Leiden University Medical Center (1)  ·  Montreal Heart Institute (1)  ·  Paul M. Tulkens (1)  ·  University Medical Center Groningen (1)  ·  Université Catholique de Louvain (1)  ·  waqqas.afif (1)

Countries

Belgium (2)  ·  Canada (2)  ·  Netherlands (2)  ·  Argentina (1)  ·  Brazil (1)  ·  France (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

A.J. van der Wekken, PhD (1)  ·  Alison Holmes, MD (1)  ·  Lucie Verret, B.Pharm, MSc (1)  ·  Paul M. Tulkens, MD, PhD (1)  ·  Waldo H Belloso, MD (1)  ·  Waqqas Afif, MD, FRCPC (1)

Results publications

PMID 16531428, PMID 16640454, PMID 19095679, PMID 19237886, PMID 21142293, PMID 22194591, PMID 22839761, PMID 23153962, PMID 24080664, PMID 25712752, PMID 25808018, PMID 26414659, PMID 26603304, PMID 3588249, PMID 1444289, PMID 1482149, PMID 16304153, PMID 17135183, PMID 17846133, PMID 18788687, PMID 19398460, PMID 20561826, PMID 21730935, PMID 21788467, PMID 21810837, PMID 2186240, PMID 21862409, PMID 21914174, PMID 23033226, PMID 23642005, PMID 24731745, PMID 24768475, PMID 25220556, PMID 25433006, PMID 25455853, PMID 25753628, PMID 26188037, PMID 36969063, PMID 38985543, PMID 6305263, PMID 9455502